Article: Nicotinamide Riboside Protects Liver Immune Cells from Alcohol-Induced Damage: Preclinical Findings

PrevNext
Liver Disease Liver Health Mitochondrial Health Preclinical

Nicotinamide Riboside Protects Liver Immune Cells from Alcohol-Induced Damage: Preclinical Findings

Synopsis

Alcohol-related liver disease (ALD) is linked to mitochondrial dysfunction and impaired energy metabolism. This study examined how ethanol damages Kupffer cells, the liver's resident immune cells, focusing on the mitochondrial unfolded protein response (UPRmt), a cellular defense that protects mitochondria. In mouse Kupffer cells, ethanol caused inflammation, oxidative stress, and mitochondrial damage, including reduced mitochondrial content and structural changes. Treatment with nicotinamide riboside (NR), a precursor of NAD+, reduced these harmful effects, improved mitochondrial health, and moderated the activation of UPRmt genes regulated by ATF5, a key transcription factor. Similar UPRmt changes were observed in mouse and human livers exposed to alcohol. These findings suggest that NR may help protect the liver from alcohol-induced damage and could be a potential therapy for ALD.

Journal

The Journal of Pathology

Share

Read more

Cardiovascular Disease

Nicotinamide Riboside Protects Kidneys after Heart Attack: Preclinical Findings

SynopsisCardiorenal syndrome type 1 occurs when acute kidney injury (AKI) develops after sudden heart problems like a heart attack (MI), increasing the risk of death. This study tested whether nico...

Read more
Diabetes

Nicotinamide Riboside Protects Gut Nerve Health and Improves Gastrointestinal Transit in Diabetes: Preclinical Findings

SynopsisDiabetes causes systemic oxidative stress that often leads to nerve damage in the enteric nervous system, impairing gut motility and causing symptoms such as constipation or diarrhea. Using...

Read more